Carl C. Schimanski - Concepedia

Author

Carl C. Schimanski

Also Known As

C C Schimanski, C Schimanski, C. C. Schimanski, C.-C. Schimanski, C.C. Schimanski, CARL C. SCHIMANSKI, Carl C Schimanski, Carl C. Schimanski, Matthias Ebert

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz German Cancer Research Center Heidelberg University University Medical Center of the Johannes Gutenberg University Mainz Klinikum Darmstadt

About

Carl C. Schimanski is an author at Johannes Gutenberg University Mainz specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	698
2	Cell Biology	3	3	195
3	Hepatology	3	3	291
4	Immunology	3	3	235
5	Health Sciences	1	1	167

Carl C. Schimanski

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer Carl C. Schimanski, Stefan Schwald, Nektaria Simiantonaki, Clinical Cancer Research	2005	256
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4 Carl C. Schimanski, R Bahre, Ines Gockel, British Journal of Cancer ImmunologyPathologyCxcr4 ExpressionCancer BiologyTumor Biology	2006	167
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer Carl C. Schimanski, G. Schmitz, Anuba Kashyap, Oncogene MedicineGene ExpressionColorectal CancerCancer GenomicsTumor Suppressor	2005	140
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings Stefan Kubicka, Richard Greil, Thierry André, Annals of Oncology Gastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2013	101
Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Carl C. Schimanski, Ulrich Linnemann, Martin R. Berger PubMed Sensitive DetectionPathologyTumor BiologyAdjacent MucosaGastrointestinal Oncology	1999	72
Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma Ines Gockel, Carl C. Schimanski, Christian Heinrich, BMC Cancer	2006	60
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure Carl C. Schimanski, Jürgen Burg, Markus Moehler, Journal of Hepatology HepatologyViral HepatitisLiver PhysiologyPathogenesisPhenprocoumon-induced Liver Disease	2004	52
Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2‐40 immunostaining Ines Gockel, Mario Domeyer, George Sgourakis, Journal of Surgical Oncology Surgical OncologyEsophageal CancerPathologySuperficial Esophageal CancerTumor Biology	2009	43
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients Markus Moehler, Martin F. Sprinzl, Murad Abdelfattah, World Journal of Gastroenterology	2009	40
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab Markus Moehler, Christian Frings, Annett Mueller, World Journal of Gastroenterology	2008	39

Page 1